期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

APP/PS1转基因鼠的骨微结构及骨密度分析 被引量：2

To analyse the bone microarchitecture and bone mineral density of APP/PS1 transgenic mice
下载PDF
导出
摘要 下载PDF阅读器目的 应用高分辨率CT（Micro-CT）定量研究APP/PS1转基因鼠（老年痴呆鼠模型）胫骨近端骨微结构及骨密度的变化.方法 3月龄雌性APP/PS1转基因鼠（n=6）和野生型小鼠（n=6）自由摄食和饮水,分别于12月龄时处死,取其胫骨,应用Micro-CT进行骨微结构及骨密度分析.结果 APP/PS1转基因组小鼠胫骨近端骨微结构、骨密度参数明显小于野生型小鼠（P〈0.05）;Micro-CT扫描图像显示APP/PS1转基因小鼠的骨小梁数目、骨小梁厚度,骨皮质厚度明显小于野生型小鼠.结论 APP/PS1转基因组小鼠胫骨近端骨微结构、骨密度参数与野生型小鼠相比存在明显的差异, APP/PS1转基因组小鼠更易患骨质疏松. Objective To quantitatively investigate the changes of bone microarchitecture and bone mineral density in proximal tibia of APP/PS1 transgenic mice （a mice model of senile dementia） by micro computer tomography. Methods 3-month-old APP/PS1 transgenic and wild-type female mice （ n = 6/group） were housed with food and tap water available ad libitum. Twelve mice were sacrifced at 12 months of age and the tibias were harvested to analyse the bone microarchitecture and bone mineral density by Micro-CT. Results Bone microarchitecture and bone mineral density in Micro-CT analysis of APP/PS1 transgenic mice were significantly lower than those of wild-type mice（ P 〈 0.05） ; the Micro-CT image of trabecular number, trabecular thickness and conical thickness in APP/PSI transgenic mice were significantly lower than those in wild-type mice. Conclusion Bone microarchitecture and bone mineral density were significantly diverse in APP/PS1 transgenic mice as compared to wild-type mice,APP/PS1 transgenic mice were liable to osteoporosis.
作者 王铜浩 杨茂伟 赵梦楠 初立伟
机构地区 中国医科大学附属第一医院骨科
出处 《中国骨质疏松杂志》 CAS CSCD 2009年第9期632-636,共5页 Chinese Journal of Osteoporosis
关键词 APP/PS1转基因鼠 野生型小鼠 骨质疏松 micro—CT 骨密度 APP/PS1 transgenic mice Wild-type mice Osteoporosis Micro-CT Bone mineral density
分类号 R681 [医药卫生—骨科学]
  • 相关文献

参考文献16

  • 1Gaggelli E,Kozlowski H,Valensin D,et al.Copper homeostasis and neurodegenerative disorders (Alzheimer's,prion,and Parkinson's diseases and amyotrophic lateral sclerosis).Chem Rev,2006,106(6):1995-2044.
  • 2Price DL,Sisodia SS.Mutant genes in familial Alzheimer's disease and transgenic models.Annu Rev Neurosci,1998,21:479-505.
  • 3Janus C,Westaway D.Transgenic mouse models of Alzheimer's disease.Physiol Behav,2001,73(5):873-886.
  • 4Müller R,van Campenhout H,van Damme B,et al.Morphometric analysis of human bone biopsies:a quantitative structural comparison of histological sections and micro-computed tomography.Bone,1998,23(1):58-66.
  • 5Müller R,Hildebrand T,Ruegsegger P.Non-invasive bone biopsy:a new method to analyse and display the three-dimensional structure of trabecular bone.Phys Med Biol,1994,39(1):145-164.
  • 6Odgaard A,Gundersen HJ.Quantification of connectivity in cancellous bone,with special emphasis on 3-D reconstructions.Bone,1993,14(2):173-182.
  • 7Oakley H,Cole SL,Logan S,et al.Intraneuronal beta-amyloid aggregates,neurodegeneration,and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:potential factors in amyloid plaque formation.J Neurosci,2006,26(40):10129-10140.
  • 8Liu L,Ikonen S,Heikkinen T,et al.Effects of fimbria-fornix lesion and amyloid pathology on spatiallearning and memory in transgenic APP+PS1 mice.Behav Brain Res,2002,134(1-2):433-445.
  • 9Feldkamp LA,Goldstein SA,Parfitt AM,et al.The direct examination of three-dimensional bone architecture in vitro by computed tomography.J Bone Miner Res,1989,4(1):3-11.
  • 10Felsenberg D,Boonen S.The bone quality framework:determinants of bone strength and their interrelationships,and implications for osteoporosis management.Clin Ther,2005,27(1):1-11.

同被引文献28

  • 1Sato Y, Honda Y, Hayashida N,et al. Vitamin K deficiency and osteopenia in elderly women with Alzheimer's disease. Arch Phys Med Rehabil, 2005,86 ( 3 ) : 576-581.
  • 2Garcia-Alloza M, Borrelli LA, Rozkalne A, et al. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem ,2007,102 (4) : 1095-1104.
  • 3Ono K, Hasegawa K, Naiki H,et al. Cureumin has potent antiamyloidoge-nic effects for Alzheirner's beta-amyloid fibrils in vitro. J Neurosci Res,2004,75 ( 6 ) :742-750.
  • 4MOiler R, van Campenhout H, van Damme B, et al. Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone,1998,23 ( 1 ) :58-66.
  • 5Muller R, Hildebrand T, Ruegsegger P. Non-invasive bone biopsy: a new method to analyse and display the three-dimensional structure of trabecular bone. Phys Med Biol, 1994, 39( 1 ) :145-164.
  • 6Odgaard A. Three-dimensional methods for quantification of cancellous bone architecture. Bone,1997,20(4) :315-328.
  • 7Tysiewicz-Dudek Alzheimer's disease M, Pietraszkiewicz F, Drozdzowska B. and osteoporosis: common risk factors or one condition predisposing to the other. Ortop Traumatol Rehabil 2008,10(4) :315-323.
  • 8French DL, Muir JM, Webber CE. The ovariectomized, mature rat model of postmenopausal osteoporosis: An assessment of the bone sparing effects of curcumin. Phytomedicine,2008,15 (12) : 1069-1078.
  • 9Fia|a M, Liu PT, Espinosa-Jeffrey A, et al. Innate immunity and transcription of MGAT-nl and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci USA ,2007,104 ( 31 ) : 12849-12854.
  • 10Zhang L, Fiala M, Cashman J, et al. Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. J Alzheimers Dis ,2006,10( 1 ) : 1-7.

引证文献2

二级引证文献3

中国骨质疏松杂志
2009年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部